Clinical trial
Is the Expression of the GLUT5 Specific Fructose Transport Protein Abnormal in Patients With Fructose Intolerance?
NCT01705171 is registered in ClinicalTrials.gov with Brain-Gut Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Is the Expression of the GLUT5 Specific Fructose Transport Protein Abnormal in Patients With Fructose Intolerance?
- Lead sponsor
- Brain-Gut Research Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2011
- Completion date
- October 31, 2013
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.